DNA-Directed RNAi (ddRNAi) to inhibit expression of the gene product (PABPN1) involved in the aetiology of the inclusion body disease, Oculopharyngeal Muscular Dystrophy (OPMD)

Project: Research

StatusFinished
Effective start/end date1/01/1230/06/13

Funding

Benitec Ltd: £169,438

ID: 21720565